Episode 9
Pembrolizumab bei PML
Hoffnung durch Checkpoint-Inhibitor?
AMBOSS Podcast – Ärztliches Wissen für Klinik und Praxis
August 18, 20198m 48s
Audio is streamed directly from the publisher (audio.podigee-cdn.net) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Hoffnung durch Checkpoint-Inhibitor?
Titel der Studie: Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
Autoren: Cortese et al.
Journal: New England Journal of Medicine (NEJM)
AMBOSS-Inhalte: Progressive multifokale Leukoenzephalopathie, Pembrolizumab beim malignen Melanom, Pembrolizumab beim Lungenkarzinom
Topics
PMLPembrolizumabAntikörper-TherapieProgressive multifokale LeukenzephalopathieCheckpoint-InhibitorKrebstherapie